2â²-Fluoro-6â²-methylene-carbocyclic adenosine phosphoramidate (FMCAP) prodrug: In vitro anti-HBV activity against the lamivudine-entecavir resistant triple mutant and its mechanism of action
Keywords: جهش های مقاوم در برابر مواد مخدر; Carbocyclic-nucleos(t)ide; Anti-HBV activity; Wild-type; Lamivudine-entecavir triple mutant; Drug-resistant mutants;